Guangzhou Bio-gene Technology Co., Ltd

Why collaborate with us?

Research Focus

We specialize in CAR-T cell therapy and have established multiple pioneering platforms, including rapid autologous CAR-T manufacturing platform, allogeneic CAR-T platform, and in vivo engineered CAR-T platform. These innovations significantly reduce the production cost of cell-based therapeutic products.
Pipeline Portfolio

Our differentiated candidate products targeting a wide range of indications, including hematological malignancies, solid tumors, and autoimmune diseases. Multiple candidates have already entered clinical trial stages.
CAR-T Manufacturing Capacity

We have the capability from antibody screening，CAR design，lentivirus packaging to CAR-T manufacture and quality control.
Leadership Team

A visionary management team with rich industry experience and successful entrepreneurial track records.

Collaboration

01

Co-development

Guangzhou Bio-gene is developing a pipeline of cell therapy products targeting malignant tumors and autoimmune diseases. We look forward to collaborating with potential partners who plan to expand into these fields and possess differentiated advantages, to jointly develop targeted products and advance them through the commercialization process.
02

Technical Services

We provide a comprehensive suite of technical services to support CAR-T product pipeline development, including antibody screening, vector design, vector preparation and production, as well as lentivirus packaging and production. We offer customized services for both research-grade and GMP-compliant plasmid vectors and lentiviruses to meet diverse client requirements.
03

Product licensing

To further unlock the market potential of our innovative therapies, we are open to collaborating with global partners through flexible commercial licensing models. We offer comprehensive or region- and indication-specific licensing options for assets within our pipeline to maximize both clinical and commercial value.